Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Urinary Incontinence Clinical Trials
Urinary Incontinence clinical trials are recruiting across 69 cities. Here are the cities with the most active studies:
Urinary Incontinence Trial Phases
29 research organizations are sponsoring urinary incontinence trials.
About Urinary Incontinence
Urinary incontinence is the involuntary loss of urine, ranging from occasional leaking to complete inability to control the bladder. Types include stress, urge, overflow, and functional incontinence. Treatment includes pelvic floor exercises, medications, devices, and surgery.
Clinical trials are advancing new treatments for urinary incontinence. Currently, 35 studies are recruiting a combined 6,260 participants across the United States. Research is being conducted by 29 organizations including Eli Lilly and Company, Ethicon, Inc., University Hospitals Cleveland Medical Center and 26 others.
2026 Urinary Incontinence Research Landscape
As of July 2026, the urinary incontinence clinical trial landscape includes 35 actively recruiting studies across 69 cities in the United States. These studies are collectively seeking 6,260 participants, with an average enrollment target of 179 per study.
The research spans multiple phases of development: 24 studies are in NA, 4 studies are in PHASE2, 2 studies are in PHASE3, 2 studies are in PHASE4, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some urinary incontinence treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 29 different organizations, including Eli Lilly and Company, Ethicon, Inc., University Hospitals Cleveland Medical Center, NICHD Pelvic Floor Disorders Network, Caldera Medical, Inc., and 24 others. The large number of sponsors reflects significant research interest and investment in urinary incontinence treatment advancement.
Geographically, urinary incontinence trials are most concentrated in Chicago, Illinois (7 trials); Durham, North Carolina (5 trials); Cleveland, Ohio (5 trials); Dallas, Texas (4 trials); Los Angeles, California (3 trials) and 7 other cities.
Featured Urinary Incontinence Studies
Highlighted recruiting studies for urinary incontinence, selected by enrollment size and research scope.
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron works in adult female participants with stress urinary incontinence (SUI) who have obesity or overweight. SUI is leaking urine during movement or activity such as coughing or exercising. Participation in the study will last about 58 weeks from screening t...
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
The goal of this clinical trial is to learn if retropubic midurethral sling (RP-MUS) or bulkamide injection (PAHG) at the time of pelvic organ prolapse repair is better from the patient's perspective. The main questions it aims to answer are: What is the average difference in the urogenital distress inventory (UDI) long form score 24 months after surgery for each procedure? Which procedure has th...
Frequently Asked Questions About Urinary Incontinence Clinical Trials
Are there urinary incontinence clinical trials near me?
Yes, there are 35 urinary incontinence clinical trials currently recruiting across 69+ cities in the United States, including Chicago, Illinois; Durham, North Carolina; Cleveland, Ohio. Browse the studies above to find one at a location convenient for you.
How do I join a urinary incontinence clinical trial?
To join a urinary incontinence clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are urinary incontinence clinical trials free?
Yes, participation in urinary incontinence clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of urinary incontinence treatments are being studied?
Current urinary incontinence clinical trials are testing a range of approaches across NA (24 studies), PHASE2 (4 studies), PHASE3 (2 studies), PHASE4 (2 studies), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 29 research organizations.
Is it safe to participate in urinary incontinence clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov